Fraudstein just surfaced with his typically poorly written and fraudulent articles intended to bash another fine company called CPRX Catalyst Pharmaceutical Partners. His article is the same old stuff he used to try to discredit AMPE. All it's doing is creating a short term buying opportunity.
Be ready for another bashing article directed against AMPE as we approach 10/29. He will very likely lunch a negative article on Ampio so shorts can cover and not get hurt by upcoming goo news from the FDA on Oct 29.
The SEC is wise to him and is watching him closer than he realizes. I have it from good sources that he is on very thin ice.
His last attempt to blast AMPE did nothing but be ready anyhow because he is almost sure to come since the short interests are very likely paying him off and they are concerned about the October 29th FDA meeting with Ampio.